NCT00043329View on ClinicalTrials.gov

Post Marketing Surveillance Study of Actimmune in Patients With Severe, Malignant Osteopetrosis

CompletedOBSERVATIONAL
Enrollment

6

Participants

Timeline

Start Date

January 31, 2002

Study Completion Date

September 30, 2005

Conditions
Osteopetrosis
Interventions
DRUG

Actimmune Registry

as administered by physician

Trial Locations (1)

94005

InterMune, Inc., Brisbane

Sponsors

Lead Sponsor

InterMune
All Listed Sponsors
lead

InterMune

INDUSTRY

NCT00043329 - Post Marketing Surveillance Study of Actimmune in Patients With Severe, Malignant Osteopetrosis | Biotech Hunter | Biotech Hunter